Associations between serum total bilirubin, obesity and type 2 diabetes

Background This study aims to examine the cross-sectional association between serum total bilirubin (STB) and type 2 diabetes (T2D) risk in the general population, and whether obesity could moderate this association. Methods We used data from the 1999-2018 National Health and Nutrition Examination Surveys (NHANES), including a total of 38,641 US adult participants who were 18 years or older. The STB was classified as the low, moderate, and high groups according to tertiles. Results We found that participants with lower STB had a significantly higher risk of T2D than those with moderate (OR = 0.81; 95% CI 0.74, 0.89; P < 0.001) and high (OR = 0.65; 95% CI 0.59, 0.73; P < 0.001) STB. Also, a significant interaction between body mass index (BMI) and STB on T2D was observed (P < 0.001). Stratified analysis showed that low STB was associated with a 20% and 27% decrease of T2D risk for moderate and high STB groups in obese patients, however, these effect estimates were smaller in the population with lower BMI (< 30 kg/m(2)). Similar associations of STB with glycohemoglobin and insulin resistance were observed. Conclusion This study suggests that STB is associated with an elevated risk of T2D. More importantly, we reported for the first time that BMI may moderate the association between bilirubin and T2D.

Automated summary

The study found that individuals with lower serum total bilirubin levels had a significantly higher risk of type 2 diabetes compared to those with moderate or high levels. Additionally, it was discovered that body mass index (BMI) may moderate the association between bilirubin and type 2 diabetes, with a stronger effect observed in obese individuals. This study suggests that serum total bilirubin is associated with an increased risk of type 2 diabetes and that this association may be influenced by obesity.